Home › Medivir: MIV-802 has been selected as a candidate drug and enters...
 

Keywords :   


Medivir: MIV-802 has been selected as a candidate drug and enters...

2014-12-22 13:31:25| Appliances - Topix.net

Medivir AB announced that MIV-802 has been selected as a candidate drug from its hepatitis C virus nucleotide polymerase inhibitor project for the treatment of HCV infection, and is entering non-clinical development. Approximately 120 million people are chronically infected with HCV globally*.

Tags: selected drug candidate enters

Category:Consumer Goods and Services

Latest from this category

All news
05.10A 'painful' Autumn statement and a 'bright' Irish budget
04.10Should you tip even if the service wasn't worth it?
04.10Ex-Harrods exec: I lost my job due to Al Fayed
04.10How worried should I be about rising oil prices?
04.10EU hits China with big taxes in electric car sales battle
04.10Builders' 2.5bn merger backed after monopoly probe
04.10Surprise surge in new US jobs in September
04.10Meta must limit data for personalised ads - EU court
Consumer Goods and Services »
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
More »